Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Cash from Investing Activities (2023 - 2025)

Fractyl Health (GUTS) has disclosed Cash from Investing Activities for 3 consecutive years, with -$8000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Investing Activities rose 96.24% year-over-year to -$8000.0, compared with a TTM value of -$787000.0 through Sep 2025, up 52.82%, and an annual FY2024 reading of -$1.8 million, down 391.64% over the prior year.
  • Cash from Investing Activities was -$8000.0 for Q3 2025 at Fractyl Health, up from -$98000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$8000.0 in Q3 2025 and bottomed at -$1.1 million in Q1 2024.
  • Average Cash from Investing Activities over 3 years is -$243454.5, with a median of -$148000.0 recorded in 2023.
  • The sharpest move saw Cash from Investing Activities plummeted 5195.0% in 2024, then surged 96.24% in 2025.
  • Year by year, Cash from Investing Activities stood at -$136000.0 in 2023, then crashed by 71.32% to -$233000.0 in 2024, then soared by 96.57% to -$8000.0 in 2025.
  • Business Quant data shows Cash from Investing Activities for GUTS at -$8000.0 in Q3 2025, -$98000.0 in Q2 2025, and -$448000.0 in Q1 2025.